Controversy over conducting clinical trials in Poland

Monika Urbaniak

doi:10.5114/jhi.2015.56823

eISSN: 2450-5722
ISSN: 2450-5927

Journal of Health Inequalities

Current issue Archive Online first About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

1/2015
vol. 1

Send email

Copy url:

abstract:

Review paper

Controversy over conducting clinical trials in Poland

Monika Urbaniak

J Health Inequal 2015; 1: 28–30

DOI: https://doi.org/10.5114/jhi.2015.56823

Online publish date: 2015/12/31

View full text Get citation

PlumX metrics:

The number of clinical trials per year carried out in Poland is relatively high, however, the Polish regulations related to performing and funding of clinical trials are not very extensive. The NIK in its audit report conlcuded “a lack of a comprehensive system of regulations concerning conducting, financing and financial control of clinical research”. The National Health Fund is an authority responsible for, among others, planning and purchasing publicly financed health services. The sponsor is obliged to manage and finance clinical trials, however many procedures performed during the research can be classified as standard medical care guaranteed by the Act on health care services financed from public funds.
There is still a need of solving the problem of financing standard health care services being a part of a clinical trial by a proper legal act.

keywords:

clinical trial, the National Health Fund, sponsor, financing of clinical trials

Journal published under the patronage of: